Bryan Lau, Ph.D. - Publications

Affiliations: 
2005 Johns Hopkins University, Baltimore, MD 
Area:
Public Health

97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rudolph JE, Calkins K, Xu X, Wentz E, Pirsl F, Visvanathan K, Lau B, Joshu C. Comparing cancer incidence in an observational cohort of Medicaid beneficiaries with and without HIV, 2001-2015. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 37831615 DOI: 10.1097/QAI.0000000000003318  0.304
2023 Joshu CE, Calkins KL, Rudolph JE, Xu X, Wentz E, Coburn SB, Kaur M, Pirsl F, Moore RD, Lau B. Lower endoscopy, early-onset and average-onset colon cancer among medicaid beneficiaries with and without HIV: A cohort study. Aids (London, England). PMID 37788111 DOI: 10.1097/QAD.0000000000003740  0.36
2023 Lesko CR, Gnang JS, Fojo AT, Hutton HE, Mccaul ME, Delaney JA, Cachay ER, Mayer KH, Crane HM, Scott Batey D, Napravnik S, Christopoulos KA, Lau B, Chander G. Alcohol use and the longitudinal HIV care continuum for people with HIV who enrolled in care between 2011-2019. Annals of Epidemiology. PMID 37442307 DOI: 10.1016/j.annepidem.2023.07.002  0.367
2023 McFall AM, Solomon SS, Lau B, Latkin C, Srikrishnan AK, Anand S, Vasudevan CK, Kumar MS, Lucas GM, H Mehta S. Respondent-driven sampling is more efficient than facility-based strategies at identifying undiagnosed people who inject drugs living with HIV in India. Drug and Alcohol Dependence. 249: 110834. PMID 37352733 DOI: 10.1016/j.drugalcdep.2023.110834  0.388
2022 Pytell JD, Li X, Thompson C, Lesko CR, McCaul ME, Hutton H, Scott Batey D, Cachay E, Mayer KH, Napravnik S, Christopoulos K, Yang C, Crane HM, Chander G, Lau B. The temporal relationship of alcohol use and subsequent self-reported health status among people with HIV. American Journal of Medicine Open. 9. PMID 37476695 DOI: 10.1016/j.ajmo.2022.100020  0.345
2022 Lesko CR, Keruly JC, Moore RD, Shen NM, Pytell JD, Lau B, Fojo AT, Mehta SH, Kipke M, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, et al. COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug and Alcohol Dependence. 109355. PMID 35331581 DOI: 10.1016/j.drugalcdep.2022.109355  0.425
2022 Pytell JD, Shen NM, Keruly JC, Lesko CR, Lau B, Fojo AT, Baum MK, Gorbach PM, Javanbakht M, Kipke M, Kirk GD, Mustanski B, Shoptaw S, Siminski S, Moore RD, et al. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug and Alcohol Dependence. 109382. PMID 35331580 DOI: 10.1016/j.drugalcdep.2022.109382  0.322
2022 Coburn SB, Dionne-Odom J, Alcaide ML, Moran CA, Rahangdale L, Golub ET, Massad LS, Seidman D, Michel KG, Minkoff H, Murphy K, Brown TT, Visvanathan K, Lau B, Althoff KN. The Association Between HIV Status, Estradiol, and Sex Hormone Binding Globulin Among Premenopausal Women in the Women's Interagency HIV Study. Journal of Women's Health (2002). PMID 35041528 DOI: 10.1089/jwh.2021.0276  0.613
2021 El-Nahal WG, Shen NM, Keruly JC, Jones JL, Fojo AT, Lau B, Manabe YC, Moore RD, Gebo KA, Lesko CR, Chander G. Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic. Aids (London, England). PMID 34711737 DOI: 10.1097/QAD.0000000000003119  0.326
2021 Kim J, Lesko CR, Fojo AT, Keruly JC, Moore RD, Chander G, Lau B. The Effect Of Buprenorphine On HIV Viral Suppression. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34171087 DOI: 10.1093/cid/ciab578  0.422
2021 Coburn SB, Shiels M, Silverberg M, Horberg M, Gill MJ, Brown TT, Visvanathan K, Connor AE, Napravnik S, Marcus J, Moore RD, Mathews WC, Mayor AM, Sterling T, Li J, ... ... Lau B, et al. Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33492023 DOI: 10.1097/QAI.0000000000002627  0.599
2020 McFall AM, Lau B, Latkin C, Srikrishnan AK, Anand S, Vasudevan CK, Mehta SH, Solomon SS. Optimizing respondent driven sampling to find undiagnosed HIV-infected people who inject drugs. Aids (London, England). PMID 33252482 DOI: 10.1097/QAD.0000000000002763  0.349
2020 Dean LT, Nonyane BAS, Ugoji C, Visvanathan K, Jacobson LP, Lau B. Economic Burden Among Gay, Bisexual, and Other Men Who Have Sex With Men Living With HIV or Living Without HIV in the Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndromes (1999). 85: 436-443. PMID 33136741 DOI: 10.1097/Qai.0000000000002478  0.484
2020 Silverberg MJ, Leyden W, Hernández-Ramírez RU, Qin L, Lin H, Justice AC, Hessol NA, Achenbach CJ, D'Souza G, Engels EA, Althoff KN, Mayor AM, Sterling TR, Kitahata MM, Bosch RJ, ... ... Lau B, et al. Timing of Antiretroviral Therapy Initiation and Risk of Cancer among Persons Living with HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32785640 DOI: 10.1093/Cid/Ciaa1046  0.719
2020 Lesko CR, Chander G, Moore RD, Lau B. Variation in estimated viral suppression associated with the definition of viral suppression used. Aids (London, England). 34: 1519-1526. PMID 32675564 DOI: 10.1097/Qad.0000000000002579  0.497
2020 Calkins KL, Chander G, Joshu CE, Visvanathan K, Fojo AT, Lesko CR, Moore RD, Lau B. A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEER. Cancer Causes & Control : Ccc. PMID 32144680 DOI: 10.1007/S10552-020-01289-X  0.467
2019 Calkins KL, Chander G, Joshu CE, Visvanathan K, Fojo AT, Lesko CR, Moore RD, Lau B. Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era. Jama Oncology. PMID 31804663 DOI: 10.1001/Jamaoncol.2019.4648  0.461
2019 Calkins K, Chander G, Joshu C, Visvanathan K, Fojo AT, Lesko C, Moore R, Lau B. Differences in five year survival after cancer diagnosis between HIV clinic enrollees and the general US population. Aids Research and Human Retroviruses. PMID 31679394 DOI: 10.1089/Aid.2019.0145  0.485
2019 Miles DRB, Bilal U, Hutton HE, Lau B, Lesko CR, Fojo A, McCaul ME, Keruly J, Moore RD, Chander G. Tobacco Smoking, Substance Use, and Mental Health Symptoms in People with HIV in an Urban HIV Clinic. Journal of Health Care For the Poor and Underserved. 30: 1083-1102. PMID 31422990 DOI: 10.1353/Hpu.2019.0075  0.334
2019 Lesko CR, Keil AP, Fojo AT, Chander G, Lau B, Moore RD. Recent Substance Use and Probability of Unsuppressed HIV Viral Load among Persons on Antiretroviral Therapy in Continuity Care. American Journal of Epidemiology. PMID 31360995 DOI: 10.1093/Aje/Kwz159  0.452
2019 Singh K, Chander G, Lau B, Edwards JK, Moore RD, Lesko CR. Association of History of Injection Drug Use with External Cause-Related Mortality Among Persons Linked to HIV Care in an Urban Clinic, 2001-2015. Aids and Behavior. PMID 30955176 DOI: 10.1007/S10461-019-02497-6  0.496
2019 Canan C, Alexander GC, Moore R, Murimi I, Chander G, Lau B. Medicaid trends in prescription opioid and non-opioid use by HIV status. Drug and Alcohol Dependence. 197: 141-148. PMID 30825794 DOI: 10.1016/J.Drugalcdep.2018.11.034  0.47
2019 Monroe AK, Lesko CR, Chander G, Lau B, Keruly J, Crane HM, Amico KR, Napravnik S, Quinlivan EB, Mugavero MJ. Ancillary service needs among persons new to HIV care and the relationship between needs and late presentation to care. Aids Care. 1-9. PMID 30776911 DOI: 10.1080/09540121.2019.1576840  0.404
2018 Hutton HE, Lesko CR, Li X, Thompson CB, Lau B, Napravnik S, Mayer KH, Mathews WC, McCaul ME, Crane HM, Fredericksen RJ, Cropsey KL, Saag M, Christopoulos K, Chander G. Alcohol Use Patterns and Subsequent Sexual Behaviors Among Women, Men who have Sex with Men and Men who have Sex with Women Engaged in Routine HIV Care in the United States. Aids and Behavior. PMID 30443807 DOI: 10.1007/S10461-018-2337-5  0.304
2018 Lau B, Lesko C. Missingness in the Setting of Competing Risks: from missing values to missing potential outcomes. Current Epidemiology Reports. 5: 153-159. PMID 30386717 DOI: 10.1007/S40471-018-0142-3  0.314
2018 Dadabhai S, Gadama Fcog L, Chamanga R, Kawalazira R, Katumbi C, Makanani B, Dula D, Hua N, Lau B, Mallewa M, Taha TE. Pregnancy outcomes in the era of universal antiretroviral treatment in sub-Saharan Africa (POISE Study). Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30272628 DOI: 10.1097/Qai.0000000000001875  0.333
2018 Nance RM, Delaney JAC, Simoni JM, Wilson IB, Mayer KH, Whitney BM, Aunon FM, Safren SA, Mugavero MJ, Mathews WC, Christopoulos KA, Eron JJ, Napravnik S, Moore RD, Rodriguez B, ... Lau B, et al. HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study. Annals of Internal Medicine. PMID 30140916 DOI: 10.7326/M17-2242  0.418
2018 Lee H, Wu XK, Genberg BL, Mugavero MJ, Cole SR, Lau B, Hogan JW. Beyond binary retention in HIV care: Predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort. Aids (London, England). PMID 30005018 DOI: 10.1097/Qad.0000000000001936  0.437
2018 Lesko CR, Keil AP, Moore RD, Chander G, Fojo AT, Lau B. Measurement of Current Substance Use in a Cohort of HIV-infected Persons in Continuity HIV Care, 2007-2015. American Journal of Epidemiology. PMID 29701832 DOI: 10.1093/Aje/Kwy092  0.343
2018 Canan CE, Chander G, Monroe AK, Gebo KA, Moore RD, Agwu AL, Alexander GC, Lau B. High-Risk Prescription Opioid use Among People Living with Hiv. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29601405 DOI: 10.1097/Qai.0000000000001690  0.459
2018 Lesko CR, Lau B, Chander G, Moore RD. Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010-2015. Aids and Behavior. PMID 29541913 DOI: 10.1007/S10461-018-2085-6  0.474
2018 Calkins KL, Canan CE, Moore RD, Lesko CR, Lau B. An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use. Bmc Medical Research Methodology. 18: 27. PMID 29523081 DOI: 10.1186/S12874-018-0484-Z  0.42
2018 Lesko CR, Jacobson LP, Althoff KN, Abraham AG, Gange SJ, Moore RD, Modur S, Lau B. Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities. International Journal of Epidemiology. PMID 29438495 DOI: 10.1093/Ije/Dyx283  0.598
2017 Bilal U, McCaul ME, Crane HM, Mathews WC, Mayer KH, Geng E, Napravnik S, Cropsey KL, Mugavero MJ, Saag MS, Hutton H, Lau B, Chander G. Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV. Alcoholism, Clinical and Experimental Research. PMID 29265385 DOI: 10.1111/acer.13583  0.33
2017 Calkins KL, Lesko CR, Chander G, Moore RD, Lau B. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen among Virally Suppressed Individuals. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29210833 DOI: 10.1097/Qai.0000000000001607  0.486
2017 Cole SR, Edwards JK, Westreich D, Lesko CR, Lau B, Mugavero MJ, Mathews WC, Eron JJ, Greenland S. Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model. Biometrical Journal. Biometrische Zeitschrift. PMID 29076182 DOI: 10.1002/Bimj.201600140  0.319
2017 Sinha S, McCaul ME, Hutton HE, Monroe AK, Alvanzo A, Lesko C, Lau B, Keruly J, Moore RD, Chander G. Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic. Journal of Substance Abuse Treatment. 82: 102-106. PMID 29021107 DOI: 10.1016/j.jsat.2017.09.009  0.408
2017 Howe CJ, Dulin-Keita A, Cole SR, Hogan JW, Lau B, Moore RD, Mathews WC, Crane HM, Drozd DR, Geng E, Boswell SL, Napravnik S, Eron JJ, Mugavero MJ. Evaluating the Population Impact of Intervening on Specific Targets to Reduce HIV Racial/Ethnic Disparities in Adulthood: a Conceptual and Methodological Framework. American Journal of Epidemiology. PMID 28992096 DOI: 10.1093/Aje/Kwx247  0.494
2017 Hutton H, Lesko CR, Chander G, Lau B, Wand GS, McCaul ME. Differential effects of perceived stress on alcohol consumption in moderate versus heavy drinking HIV-infected women. Drug and Alcohol Dependence. 178: 380-385. PMID 28704766 DOI: 10.1016/J.Drugalcdep.2017.05.021  0.407
2017 Presti RM, Flores SC, Palmer BE, Atkinson JJ, Lesko CR, Lau B, Fontenot AP, Roman J, McDyer JF, Twigg HL. Mechanisms Underlying HIV Associated Non-infectious Lung Disease. Chest. PMID 28427967 DOI: 10.1016/J.Chest.2017.04.154  0.425
2017 Rebeiro PF, Abraham AG, Horberg MA, Althoff KN, Yehia BR, Buchacz K, Lau BM, Sterling TR, Gange SJ. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada. Aids Patient Care and Stds. 31: 129-144. PMID 28282246 DOI: 10.1089/Apc.2016.0178  0.735
2016 Haines CF, Fleishman JA, Yehia BR, Lau B, Berry SA, Agwu AL, Moore RD, Gebo KA. Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities. Journal of Acquired Immune Deficiency Syndromes (1999). 73: 340-347. PMID 27763997 DOI: 10.1097/QAI.0000000000001114  0.444
2016 Barai N, Monroe A, Lesko C, Lau B, Hutton H, Yang C, Alvanzo A, McCaul ME, Chander G. The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV. Aids and Behavior. PMID 27752873 DOI: 10.1007/s10461-016-1580-x  0.36
2016 Lesko CR, Tong W, Moore RD, Lau B. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort. Aids and Behavior. PMID 27752872 DOI: 10.1007/S10461-016-1585-5  0.543
2016 Zelaya CE, Le Minh N, Lau B, Latkin CA, Viet Ha T, Minh Quan V, Mo TT, Sripaipan T, Davis WW, Celentano DD, Frangakis C, Go VF. The Effect of a Multi-Level Intervention on the Initiation of Antiretroviral Therapy (ART) among HIV-Infected Men Who Inject Drugs and Were Diagnosed Late in Thai Nguyen, Vietnam. Plos One. 11: e0161718. PMID 27579772 DOI: 10.1371/Journal.Pone.0161718  0.427
2016 Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, et al. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. The Journal of Infectious Diseases. 214: 862-72. PMID 27559122 DOI: 10.1093/Infdis/Jiw085  0.706
2016 Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie E, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, et al. Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27506682 DOI: 10.1093/Cid/Ciw531  0.63
2016 Crane HM, Nance RM, Merrill JO, Hutton H, Chander G, McCaul ME, Mathews WC, Fredericksen R, Simoni JM, Mayer K, Mugavero MJ, Willig JH, Burkholder G, Drozd DR, Mimiaga M, ... Lau B, et al. Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders. Aids Care. 1-8. PMID 27482893 DOI: 10.1080/09540121.2016.1204418  0.343
2016 Lesko CR, Edwards JK, Moore RD, Lau B. A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of injection drug use. Aids (London, England). PMID 27314178 DOI: 10.1097/Qad.0000000000001183  0.433
2016 Shepherd BE, Liu Q, Mercaldo N, Jenkins CA, Lau B, Cole SR, Saag MS, Sterling TR. Comparing results from multiple imputation and dynamic marginal structural models for estimating when to start antiretroviral therapy. Statistics in Medicine. PMID 27264354 DOI: 10.1002/Sim.7007  0.413
2016 Monroe AK, Lau B, Mugavero MJ, Mathews WC, Mayer KC, Napravnik S, Hutton HE, Kim HH, Jabour S, Moore RD, McCaul ME, Christopoulos KA, Crane HC, Chander G. Heavy Alcohol Use is Associated with Worse Retention in HIV Care. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27243904 DOI: 10.1097/QAI.0000000000001083  0.37
2016 Bilal U, Lau B, Lazo M, McCaul ME, Hutton HE, Sulkowski MS, Moore RD, Chander G. Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV. Aids Patient Care and Stds. 30: 200-7. PMID 27158847 DOI: 10.1089/Apc.2016.0010  0.389
2016 Koethe JR, Jenkins CA, Lau B, Shepherd BE, Wester W, Rebeiro PF, Silverberg MJ, Thorne JE, Gill J, Mayor AM, Willig A, Bosch R, Horberg MA, Justice AC, Sterling TR, et al. Higher Time-updated Body Mass Index: Association with Improved CD4+ Cell Recovery on HIV Treatment. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27116044 DOI: 10.1097/Qai.0000000000001035  0.404
2016 Lesko CR, Moore RD, Tong W, Lau B. Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014. Aids (London, England). PMID 26990627 DOI: 10.1097/Qad.0000000000001087  0.502
2015 Rebeiro PF, Althoff KN, Lau B, Gill J, Abraham AG, Horberg MA, Kitahata MM, Yehia BR, Samji H, Brooks JT, Buchacz K, Napravnik S, Silverberg MJ, Rachlis A, Gebo KA, et al. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. American Journal of Epidemiology. 182: 952-60. PMID 26578717 DOI: 10.1093/aje/kwv181  0.729
2015 Howe CJ, Cole SR, Lau B, Napravnik S, Eron JJ. Selection bias due to loss to follow up in cohort studies. Epidemiology (Cambridge, Mass.). PMID 26484424 DOI: 10.1097/Ede.0000000000000409  0.331
2015 Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, et al. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Annals of Internal Medicine. 163: 507-18. PMID 26436616 DOI: 10.7326/M14-2768  0.661
2015 Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, Blashill AJ, Willig A, Wester CW, Silverberg MJ, Gill J, et al. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. Aids Research and Human Retroviruses. PMID 26352511 DOI: 10.1089/Aid.2015.0147  0.452
2015 Chander G, Hutton HE, Lau B, Xu X, McCaul ME. Brief Intervention Decreases Drinking Frequency in HIV-Infected, Heavy Drinking Women: Results of a Randomized Controlled Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 25967270 DOI: 10.1097/Qai.0000000000000679  0.49
2015 Sam TS, Hutton HE, Lau B, McCaul ME, Keruly J, Moore R, Chander G. Antiretroviral Therapy Use, Medication Adherence, and Viral Suppression Among PLWHA with Panic Symptoms. Aids and Behavior. PMID 25903506 DOI: 10.1007/S10461-015-1064-4  0.328
2015 Cole SR, Lau B, Eron JJ, Brookhart MA, Kitahata MM, Martin JN, Mathews WC, Mugavero MJ. Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. American Journal of Epidemiology. 181: 238-45. PMID 24966220 DOI: 10.1093/Aje/Kwu122  0.364
2014 Ishwaran H, Gerds TA, Kogalur UB, Moore RD, Gange SJ, Lau BM. Random survival forests for competing risks. Biostatistics (Oxford, England). 15: 757-73. PMID 24728979 DOI: 10.1093/Biostatistics/Kxu010  0.528
2013 Bhasin B, Lau B, Atta MG, Fine DM, Estrella MM, Schwartz GJ, Lucas GM. HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C. Plos One. 8: e82028. PMID 24376511 DOI: 10.1371/Journal.Pone.0082028  0.427
2013 Salter ML, Lau B, Mehta SH, Go VF, Leng S, Kirk GD. Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections. Journal of Acquired Immune Deficiency Syndromes (1999). 64: 488-95. PMID 23978997 DOI: 10.1097/Qai.0B013E3182A7Ee2E  0.366
2013 Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, ... Lau B, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1174-82. PMID 23315317 DOI: 10.1093/Cid/Cit003  0.749
2012 Kowalski S, Colantuoni E, Lau B, Keruly J, McCaul ME, Hutton HE, Moore RD, Chander G. Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 455-61. PMID 22955054 DOI: 10.1097/Qai.0B013E3182712D39  0.343
2012 Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. Aids (London, England). 26: 1907-15. PMID 22824630 DOI: 10.1097/Qad.0B013E328357F5Ed  0.435
2012 Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1026-34. PMID 22291097 DOI: 10.1093/Cid/Cir1012  0.524
2012 Lau B, Gange S, Cole SR. Clarification and correction Statistics in Medicine. 31: 1777-1778. DOI: 10.1002/Sim.4468  0.367
2011 Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 1256-64. PMID 21976463 DOI: 10.1093/Cid/Cir673  0.544
2011 Mugavero MJ, Napravnik S, Cole SR, Eron JJ, Lau B, Crane HM, Kitahata MM, Willig JH, Moore RD, Deeks SG, Saag MS. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 927-35. PMID 21890751 DOI: 10.1093/Cid/Cir526  0.377
2011 Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, et al. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. The Journal of Infectious Diseases. 204: 893-901. PMID 21849286 DOI: 10.1093/Infdis/Jir421  0.571
2011 Abraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron J, Harrigan R, Gill MJ, Kitahata M, Klein M, Napravnik S, Rachlis A, Rodriguez B, Rourke S, Benson C, et al. Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. American Journal of Epidemiology. 174: 727-35. PMID 21813792 DOI: 10.1093/Aje/Kwr141  0.571
2011 Lau B, Cole SR, Gange SJ. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry. Statistics in Medicine. 30: 654-65. PMID 21337360 DOI: 10.1002/Sim.4123  0.589
2011 Neblett RC, Hutton HE, Lau B, McCaul ME, Moore RD, Chander G. Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. Journal of Women's Health (2002). 20: 279-86. PMID 21281111 DOI: 10.1089/Jwh.2010.2043  0.438
2010 Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA. Virologic and immunologic response to HAART, by age and regimen class. Aids (London, England). 24: 2469-79. PMID 20829678 DOI: 10.1097/Qad.0B013E32833E6D14  0.656
2010 Lau B, Chander G, Gange SJ, Moore RD. Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study. Aids Research and Therapy. 7: 25. PMID 20653950 DOI: 10.1186/1742-6405-7-25  0.606
2010 Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, Moore RD. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Annals of Internal Medicine. 152: 704-11. PMID 20513828 DOI: 10.7326/0003-4819-152-11-201006010-00003  0.441
2010 Cole SR, Napravnik S, Mugavero MJ, Lau B, Eron JJ, Saag MS. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. American Journal of Epidemiology. 171: 198-205. PMID 20007202 DOI: 10.1093/Aje/Kwp347  0.469
2010 Silverberg MJ, Lau B, Jing Y, D'Souza G, Engels EA, Gill J, Goedert JJ, Kirk GD, Justice A, Dubrow R. Risk of anal cancer in HIV-infected patients and HIV-uninfected controls in North America Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A70  0.533
2009 Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. American Journal of Epidemiology. 170: 244-56. PMID 19494242 DOI: 10.1093/Aje/Kwp107  0.601
2009 Lau B, Gange SJ, Kirk GD, Moore RD. Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies. Epidemiology (Cambridge, Mass.). 20: 664-72. PMID 19478669 DOI: 10.1097/EDE.0b013e3181a71519  0.6
2009 Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, ... ... Lau B, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. The New England Journal of Medicine. 360: 1815-26. PMID 19339714 DOI: 10.1056/Nejmoa0807252  0.585
2009 Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, et al. Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. The Journal of Infectious Diseases. 199: 1301-9. PMID 19338474 DOI: 10.1086/597759  0.306
2008 Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. The Journal of Infectious Diseases. 197: 1548-57. PMID 18422458 DOI: 10.1086/587994  0.423
2008 Lau B, Cole SR, Moore RD, Gange SJ. Evaluating competing adverse and beneficial outcomes using a mixture model. Statistics in Medicine. 27: 4313-27. PMID 18416435 DOI: 10.1002/Sim.3293  0.596
2007 Lau B, Gange SJ, Moore RD. Interval and clinical cohort studies: epidemiological issues. Aids Research and Human Retroviruses. 23: 769-76. PMID 17604539 DOI: 10.1089/Aid.2006.0171  0.551
2007 Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 179-87. PMID 17075385 DOI: 10.1097/01.qai.0000247229.68246.c5  0.552
2006 Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 411-7. PMID 17099312 DOI: 10.1097/01.Qai.0000243121.44659.A4  0.38
2006 Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ. C-reactive protein is a marker for human immunodeficiency virus disease progression. Archives of Internal Medicine. 166: 64-70. PMID 16401812 DOI: 10.1001/Archinte.166.1.64  0.665
2005 Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 620-5. PMID 16044017  0.634
2004 Lau B, Gange SJ. Methods for the analysis of continuous biomarker assay data with increased sensitivity. Epidemiology (Cambridge, Mass.). 15: 724-32. PMID 15475722 DOI: 10.1097/01.ede.0000142154.86749.e4  0.481
2003 Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men. Aids (London, England). 17: 2035-44. PMID 14502006 DOI: 10.1097/00002030-200309260-00004  0.658
2003 Gange SJ, Lau B, Phair J, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. Aids (London, England). 17: 119-21. PMID 12478077 DOI: 10.1097/00002030-200301030-00016  0.604
2001 Gange SJ, Mellors JW, Lau B, Detels R, Phair JP, Muñoz A, Margolick JB. Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression. Aids Research and Human Retroviruses. 17: 1223-9. PMID 11559421 DOI: 10.1089/088922201750461276  0.654
2000 Anastos K, Gange SJ, Lau B, Weiser B, Detels R, Giorgi JV, Margolick JB, Cohen M, Phair J, Melnick S, Rinaldo CR, Kovacs A, Levine A, Landesman S, Young M, et al. Association of race and gender with HIV-1 RNA levels and immunologic progression. Journal of Acquired Immune Deficiency Syndromes (1999). 24: 218-26. PMID 10969345 DOI: 10.1097/00126334-200007010-00004  0.621
2000 Anastos K, Gange SJ, Lau B, Weiser B, Detels R, Giorgi JV, Margolick JB, Cohen M, Phair J, Melnick S, Rinaldo CR, Kovacs A, Levine A, Landesman S, Young M, et al. Association of Race and Gender With HIV-1 RNA Levels and Immunologic Progression Journal of Acquired Immune Deficiency Syndromes. 24: 218-226. DOI: 10.1097/00042560-200007010-00004  0.578
Show low-probability matches.